• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Madrigal Pharmaceuticals, Inc. - Common Stock (NQ:MDGL)

435.01 -1.86 (-0.43%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 468,970
Open 435.01
Bid (Size) 424.00 (40)
Ask (Size) 440.00 (40)
Prev. Close 436.87
Today's Range 424.49 - 448.15
52wk Range 265.00 - 615.00
Shares Outstanding 17,103,395
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) Reports Q4 2025 Revenue Beat and Significant EPS Miss ↗
February 19, 2026
Via Chartmill
News headline image
Agios Stock Down 16% in a Year as Fund Cuts Stake by $5.6 Million After 50% November Crash ↗
February 17, 2026
Agios Pharmaceuticals targets rare blood disorders with a marketed anemia drug and a focused clinical-stage pipeline. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
-26.7%
-26.7%
1 Month
-9.5%
-9.5%
3 Month
-26.0%
-26.0%
6 Month
+5.5%
+5.5%
1 Year
+35.0%
+35.0%

More News

Read More
News headline image
Cogent Biosciences Stock Soars 346% in a Year, but One Fund Just Sold Off $4.5 Million ↗
February 17, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Structure Therapeutics Stock Up 187% in One Year as Fund Trims $8 Million From Stake ↗
February 17, 2026
Via The Motley Fool
Madrigal Doubles Down On MASH With A $4.4 Billion Licensing Deal With China’s Ribo ↗
February 11, 2026
Via Stocktwits
News headline image
Earnings Scheduled For November 4, 2025 ↗
November 04, 2025
Via Benzinga
News headline image
Kymera Therapeutics Stock Up 120% in 1 Year as Fund Adds $3 Million More ↗
February 17, 2026
Via The Motley Fool
News headline image
Why Madrigal Pharmaceuticals Stock Slumped on Tuesday ↗
January 06, 2026
Via The Motley Fool
News headline image
Ignore Nektar Therapeutics Stock in 2026 and Load Up on This One Instead ↗
January 05, 2026
Via The Motley Fool
Topics Bankruptcy
News headline image
2 Tailwinds Behind Novo Nordisk Stock Heading Into 2026 ↗
January 03, 2026
Via The Motley Fool
News headline image
2 Predictions for Novo Nordisk in 2026 ↗
December 14, 2025
Via The Motley Fool
News headline image
2 Stocks Up Over 600% in the Past 3 Years With More Room to Run ↗
December 09, 2025
Via The Motley Fool
Topics Intellectual Property
News headline image
This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones ↗
December 03, 2025
Via The Motley Fool
Topics Initial Public Offering Regulatory Compliance
News headline image
Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash ↗
November 28, 2025
Via The Motley Fool
Topics Lawsuit Regulatory Compliance
News headline image
Biotech Fund Reveals $15 Million MoonLake Exit After Stock’s 90% Crash ↗
November 27, 2025
Via The Motley Fool
Topics Lawsuit Regulatory Compliance
News headline image
This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones ↗
November 27, 2025
Via The Motley Fool
Topics Initial Public Offering Regulatory Compliance
News headline image
Biotech Fund Dumps $12.3 Million in Crinetics Stock as Shares Remain 19% Lower on the Year ↗
November 27, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Madrigal Pharma Stock Sees Buyout Hype – Retail Predicts ‘Huge’ Deal On Liver Disease Drug Momentum ↗
November 24, 2025
Via Stocktwits
News headline image
Nvidia To Rally Around 72%? Here Are 10 Top Analyst Forecasts For Thursday ↗
November 20, 2025
Via Benzinga
News headline image
Expedia, Sandisk and Penumbra Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 3-Nov. 7): Are the Others in Your Portfolio? ↗
November 09, 2025
Via Benzinga
News headline image
Madrigal Pharmaceuticals (NASDAQ:MDGL) Q3 2025 Earnings: Revenue Beat and EPS Miss Drive Pre-Market Surge ↗
November 04, 2025
Via Chartmill
News headline image
A Look Ahead: Madrigal Pharmaceuticals's Earnings Forecast ↗
November 03, 2025
Via Benzinga
News headline image
Beyond The Numbers: 10 Analysts Discuss Madrigal Pharmaceuticals Stock ↗
October 15, 2025
Via Benzinga
News headline image
6 Stocks Goldman Sachs Says Are Poised For Potential Acquisition In Next 12 Months — Including A Huge 200% Winner ↗
September 30, 2025
Via Benzinga
News headline image
A Glimpse Into The Expert Outlook On Madrigal Pharmaceuticals Through 7 Analysts ↗
September 29, 2025
Via Benzinga

Frequently Asked Questions

Is Madrigal Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Madrigal Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Madrigal Pharmaceuticals, Inc. - Common Stock trade on?
Madrigal Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Madrigal Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Madrigal Pharmaceuticals, Inc. - Common Stock is MDGL on the Nasdaq Stock Market
What is the current price of Madrigal Pharmaceuticals, Inc. - Common Stock?
The current price of Madrigal Pharmaceuticals, Inc. - Common Stock is 435.01
When was Madrigal Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Madrigal Pharmaceuticals, Inc. - Common Stock was at 02/20/26 04:00 PM ET
What is the market capitalization of Madrigal Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Madrigal Pharmaceuticals, Inc. - Common Stock is 7.44B
How many shares of Madrigal Pharmaceuticals, Inc. - Common Stock are outstanding?
Madrigal Pharmaceuticals, Inc. - Common Stock has 7B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap